Geneos Therapeutics specializes in personalized therapeutic cancer vaccines, utilizing its proprietary GT-EPIC™ platform to create customized immunotherapies. As a Phase 2 biotherapeutics company, it aims to redefine cancer treatment, delivering tailored solutions that address the unique needs of each patient in the biotechnology and life sciences sector.